Cargando…
1171. Lower Mortality with Adjuvant Corticosteroid Therapy in non-HIV Infected Patients with pneumocystis jirovecii pneumonia: A Single US Cohort Study and a Proposed Novel Mechanism of Corticosteroids
BACKGROUND: Pneumocystis jirovecii pneumonia (PJP) remains a cause of mortality in HIV-negative patients. The clinical benefit of adjuvant corticosteroids given at the time of PJP antimicrobial therapy in these patients is uncertain. This study aimed to determine if corticosteroids reduced mortality...
Autores principales: | Mundo, William, Franco-Paredes, Carlos, Johnson, Steven C, Shapiro, Leland, Henao-Martinez, Andres |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777470/ http://dx.doi.org/10.1093/ofid/ofaa439.1357 |
Ejemplares similares
-
Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit
por: Gharamti, Amal A., et al.
Publicado: (2021) -
Lower Mortality Associated With Adjuvant Corticosteroid Therapy in Non-HIV-Infected Patients With Pneumocystis jirovecii Pneumonia: A Single-Institution Retrospective US Cohort Study
por: Mundo, William, et al.
Publicado: (2020) -
Pneumocystis jirovecii pneumonia following corticosteroid therapy
por: Garça, Magda, et al.
Publicado: (2023) -
Previous corticosteroid exposure associates with an increased Pneumocystis jirovecii pneumonia mortality among HIV-negative patients: a global research network with a follow-up multicenter case-control study
por: Vargas Barahona, Lilian, et al.
Publicado: (2023) -
The Infectious Danger of Corticosteroids: A Fatal Case of Pneumocystis Jirovecii Pneumonia in a Non-HIV Patient Following Corticosteroid Use with Prophylaxis
por: Jagannathan, Megha
Publicado: (2019)